5価の世界市場レポート 2024

5価の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.6%の年間複合成長率（CAGR）で31億7,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、進行中の世界の予防接種の取り組み、新しい地域へのワクチン接種プログラムの拡大、研究開発の取り組みの増加、ワクチンアクセス改善のための協力によるものと考えられます。予測期間の主な動向には、世界の保健イニシアチブと資金提供、国民啓発と教育キャンペーン、政府の政策と規制の枠組み、ワクチン製造における技術革新による支援が含まれます。

5価市場は、ジフテリアの蔓延により成長する準備ができています。伝染性が高く重篤な疾患であるジフテリアを引き起こす細菌であるジフテリア菌は、摂食困難、呼吸困難、皮膚潰瘍の発生の可能性など、重大な健康上の課題を引き起こします。 5価ワクチンは、子供向けの5価予防接種の3回接種スケジュールを通じて、ジフテリア疾患に対する保護を提供します。このジフテリアの有病率の増加により、5価ワクチンの需要が増加しています。注目に値する例は、2022年に世界保健機関によって報告されたデータで、国際保健規則の報告プロセスを通じて記録されたジフテリア症例の異常な数を浮き彫りにしています。 7か国で144件のジフテリア症例が報告されており、難民申請者に重大な影響を与えています。臨床的に適合する症例は69%を占め、臨床検査により確認された毒素原性ジフテリア症例は31%、そして疑わしい症例は2%でした。したがって、ジフテリアの蔓延は5価市場の成長の原動力となっています。

5価市場は、ヘルスケア費の増加により成長が見込まれています。ヘルスケア支出には、特定の期間内にヘルスケアサービスの提供に割り当てられた金銭的およびその他のリソースの合計が含まれます。 5価ワクチンの文脈では、ヘルスケア支出には5つの異なる疾患を対象としたワクチンの開発、生産、配布、投与に充てられる財源が含まれます。 2023年12月、米国に本拠を置く連邦機関であるメディケア・メディケイド・サービスセンターは、2022年の米国のヘルスケア支出が4.1％増加し、総額4兆5,000億米ドル（個人1人当たり1万3,493米ドルに相当）に達すると報告しました。このヘルスケア支出の大幅な増加は、5価市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の5価市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• スチボグルコン酸ナトリウム
• アンチモン酸メグルミン
• 世界の5価市場、製剤タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 凍結乾燥
• 液体
• 世界の5価市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 地域および国の分析

• 世界の5価市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の5価市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 5価市場の競合情勢
• 5価市場の企業プロファイル
  • Pfizer Inc.
  • Merck &Co. Inc.
  • Novartis AG
  • Sanofi SA
  • Bristol-Myers Squibb Company

第31章 その他の主要および革新的な企業

• LG Chem Ltd.
• GlaxoSmithKline plc
• Shandong Xinhua Pharmaceutical Company Limited
• Mitsubishi Tanabe Pharma Corporation
• PT Bio Farma（Persero）
• Shantha Biotechnics Limited
• Seqirus Holdings plc
• Biological E. Limited
• Serum Institute of India Private Limited
• Indian Immunologicals Limited
• Incepta Pharmaceuticals Limited
• Shanghai Institute of Biological Products Co. Ltd.
• Changchun Changsheng Biotechnology Co. Ltd
• Adimmune Corporation
• AJ Vaccines

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Pentavalent refers to a vaccine that safeguards children against five life-threatening diseases. Among these diseases, it includes protection against rotavirus infection, which can cause symptoms such as fever, vomiting, and diarrhea in infants and young children.

The primary types of pentavalent vaccines include sodium stibogluconate and meglumine antimoniate. Lyophilization, a method of removing water, is commonly employed to preserve perishable products, extend shelf life, or facilitate easier transportation. Formulation types encompass lyophilized and liquid variations, serving diverse applications in hospitals, pharmacies (both retail and online), and healthcare settings.

The pentavalent market research report is one of a series of new reports from The Business Research Company that provides pentavalent market statistics, including pentavalent industry global market size, regional shares, competitors with a pentavalent market share, detailed pentavalent market segments, market trends and opportunities, and any further data you may need to thrive in the pentavalent industry. This pentavalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pentavalent market size has grown steadily in recent years. It will grow from $2.53 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth observed in the historical period can be attributed to global immunization initiatives, government vaccination programs, the prevention of multiple diseases, increased public health awareness, and international partnerships and funding.

The pentavalent market size is expected to see steady growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The anticipated growth in the forecast period can be attributed to ongoing global immunization efforts, the expansion of vaccination programs into new geographies, increased research and development initiatives, and collaborations for improved vaccine access. Major trends in the forecast period include support from global health initiatives and funding, public awareness and education campaigns, government policies and regulatory frameworks, and technological innovations in vaccine manufacturing.

The pentavalent market is poised for growth, driven by the increasing prevalence of diphtheria. Corynebacterium diphtheriae, a bacterium causing the highly contagious and severe disease diphtheria, poses significant health challenges, including difficulties with eating, breathing, and the potential development of skin ulcers. The pentavalent vaccine offers protection against Diphtheria diseases through a 3-dose schedule of pentavalent immunization for children. This rise in the prevalence of diphtheria has led to an increased demand for pentavalent vaccines. A noteworthy example is the data reported by the World Health Organization in 2022, highlighting an unusually high number of diphtheria cases recorded through the International Health Regulations reporting process. Seven nations reported 144 instances of diphtheria, with a significant impact on asylum seekers. Clinically compatible cases constituted 69%, toxigenic diphtheria cases confirmed by laboratory testing were 31%, and 2% were suspected cases. Consequently, the escalating prevalence of diphtheria is a driving force behind the growth of the pentavalent market.

The pentavalent market is expected to experience growth, propelled by the increasing healthcare expenditure. Healthcare expenditure encompasses the total resources, both monetary and other, allocated for the provision of healthcare services within a specific timeframe. In the context of pentavalent vaccines, healthcare expenditure involves financial resources dedicated to the development, production, distribution, and administration of vaccines targeting five different diseases. In December 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported a 4.1 percent increase in healthcare expenditures in the United States in 2022, reaching a total of $4.5 trillion, equivalent to $13,493 per individual. This substantial rise in healthcare expenditure is a key factor driving the growth of the pentavalent market.

Product innovation has become a prominent and widely adopted trend in the pentavalent market, with major companies actively focusing on the development of innovative products to strengthen their market positions. An illustrative example is Pfizer, a US-based pharmaceutical company operating in the pentavalent vaccines market. In December 2022, Pfizer secured approval from The United States Food and Drug Administration (FDA), a federal agency of the Department of Health and Human Services, for its Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents. This vaccine is designed to prevent meningococcal disease in individuals aged 10 to 25. The unique aspect of the MenABCWY vaccine lies in its combination of components from two vaccines into one, providing protection against the meningococcal serogroups that are responsible for the majority of invasive meningococcal diseases. This strategic product innovation reflects a commitment to addressing public health needs and advancing the effectiveness of vaccines in preventing serious illnesses.

Major companies in the pentavalent market are actively focused on developing innovative solutions, particularly in the realm of pentavalent immunization vaccines. These vaccines represent a combination designed to protect against five different diseases. A notable example is Pfizer, a US-based pharmaceutical company, which in October 2023, announced FDA approval for its 'Penbraya' pentavalent vaccine. This groundbreaking vaccine is the first and only one providing protection against the five most prevalent meningococcal serogroups-A, B, C, W-135, and Y-in individuals aged 10 through 25 years. The Penbraya vaccine incorporates elements from the Trumenba meningococcal group B vaccine and the Nimenrix meningococcal groups A, C, W-135, and Y conjugate vaccine. It has been identified as effective in offering protection against the five meningococcal serogroups responsible for the majority of global cases of invasive meningococcal disease. This signifies a strategic move towards advancing comprehensive immunization solutions to address significant public health concerns.

In January 2022, Ardian, a private equity investment firm headquartered in France, successfully completed the acquisition of Biofarma Group for an undisclosed sum. This strategic transaction positions Ardian to facilitate increased consolidation and international expansion within the market. Biofarma Group, an Italy-based entity specializing in the pentavalent vaccines market, now stands as a key asset within Ardian's portfolio, contributing to the company's broader strategic goals and market positioning.

Major companies operating in the pentavalent market report are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, LG Chem Ltd., GlaxoSmithKline PLC, Shandong Xinhua Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, PT Bio Farma (Persero), Shantha Biotechnics Limited, Seqirus Holdings PLC, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co. Ltd., Changchun Changsheng Biotechnology Co. Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, Biogenics Pvt. Ltd., GreenSignal Bio Pharma Limited, PanGen Biotech Inc., Biomed Pvt. Ltd., Maiden Pharmaceuticals Limited, Panacea Drugs Limited, Crucell N.V., Bharat Biotech International Limited, Vacsera Ltd., Vacunas Finlay S.A., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co. Ltd.

Asia-Pacific was the largest region in the pentavalent market in 2023. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pentavalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pentavalent market consists of sales of pentavalent vaccines such as those for diphtheria, pertussis, tetanus, hepatitis B, and Hib that treat a child against potentially fatal diseases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pentavalent Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pentavalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pentavalent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pentavalent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Sodium Stibogluconate; Meglumine Antimoniate
• 2) By Formulation Type: Lyophilized; Liquid
• 3) By Application: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pentavalent Market Characteristics

3. Pentavalent Market Trends And Strategies

4. Pentavalent Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pentavalent Market Size and Growth

• 5.1. Global Pentavalent Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pentavalent Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pentavalent Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pentavalent Market Segmentation

• 6.1. Global Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Sodium Stibogluconate
• Meglumine Antimoniate
• 6.2. Global Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Lyophilized
• Liquid
• 6.3. Global Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Pentavalent Market Regional And Country Analysis

• 7.1. Global Pentavalent Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pentavalent Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pentavalent Market

• 8.1. Asia-Pacific Pentavalent Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pentavalent Market

• 9.1. China Pentavalent Market Overview
• 9.2. China Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pentavalent Market

• 10.1. India Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pentavalent Market

• 11.1. Japan Pentavalent Market Overview
• 11.2. Japan Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pentavalent Market

• 12.1. Australia Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pentavalent Market

• 13.1. Indonesia Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pentavalent Market

• 14.1. South Korea Pentavalent Market Overview
• 14.2. South Korea Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pentavalent Market

• 15.1. Western Europe Pentavalent Market Overview
• 15.2. Western Europe Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pentavalent Market

• 16.1. UK Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pentavalent Market

• 17.1. Germany Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pentavalent Market

• 18.1. France Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pentavalent Market

• 19.1. Italy Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pentavalent Market

• 20.1. Spain Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pentavalent Market

• 21.1. Eastern Europe Pentavalent Market Overview
• 21.2. Eastern Europe Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pentavalent Market

• 22.1. Russia Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pentavalent Market

• 23.1. North America Pentavalent Market Overview
• 23.2. North America Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pentavalent Market

• 24.1. USA Pentavalent Market Overview
• 24.2. USA Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pentavalent Market

• 25.1. Canada Pentavalent Market Overview
• 25.2. Canada Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pentavalent Market

• 26.1. South America Pentavalent Market Overview
• 26.2. South America Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pentavalent Market

• 27.1. Brazil Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pentavalent Market

• 28.1. Middle East Pentavalent Market Overview
• 28.2. Middle East Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pentavalent Market

• 29.1. Africa Pentavalent Market Overview
• 29.2. Africa Pentavalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pentavalent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pentavalent Market Competitive Landscape And Company Profiles

• 30.1. Pentavalent Market Competitive Landscape
• 30.2. Pentavalent Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co. Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi SA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bristol-Myers Squibb Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pentavalent Market Other Major And Innovative Companies

• 31.1. LG Chem Ltd.
• 31.2. GlaxoSmithKline plc
• 31.3. Shandong Xinhua Pharmaceutical Company Limited
• 31.4. Mitsubishi Tanabe Pharma Corporation
• 31.5. PT Bio Farma (Persero)
• 31.6. Shantha Biotechnics Limited
• 31.7. Seqirus Holdings plc
• 31.8. Biological E. Limited
• 31.9. Serum Institute of India Private Limited
• 31.10. Indian Immunologicals Limited
• 31.11. Incepta Pharmaceuticals Limited
• 31.12. Shanghai Institute of Biological Products Co. Ltd.
• 31.13. Changchun Changsheng Biotechnology Co. Ltd
• 31.14. Adimmune Corporation
• 31.15. AJ Vaccines

32. Global Pentavalent Market Competitive Benchmarking

33. Global Pentavalent Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pentavalent Market

35. Pentavalent Market Future Outlook and Potential Analysis

• 35.1 Pentavalent Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pentavalent Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pentavalent Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer